Live
Endpoints NewsNovo Holdings’ assets fell by a third in 2025 as Novo Nordisk’s value sankThermo FisherWhere is Trump going in Cincinnati? What to know about the 2 locations - Cincinnati EnquirerThermo FisherPresident Trump talks prescription prices, Iran war during Thermo Fisher visit - WLWTRoche MediaMore biotech deals ahead for Roche - AxiosFierceBiotechHow a new tool for large-scale gene editing could power novel genetic medicinesFierceBiotechStryker hit by international cyberattack linked to pro-Iran groupFierceBiotechEvotec reveals sweeping 800-person layoffs, more site closures as restructuring rolls onFierceBiotechAgilent to acquire Biocare in $950M 'complementary combination'Endpoints NewsEvotec plans up to 800 job cuts, four site closuresEndpoints NewsFDA merges adverse event trackers into one databaseThermo FisherTrump talks prescription costs, Iran war at Thermo Fisher Scientific - Cincinnati CityBeatBioPharma DiveBiogen builds case for Spinraza successor with fresh data
BioWorld Dec 19, 2025

Biomarin buying rare disease company Amicus for $4.8B

Biomarin buying rare disease company Amicus for $4.8B

Original
Body unavailable. Use the original source.

Directory

59 All